‘Betrayal of public trust’: Pfizer under fire for resisting Paxlovid compulsory license
‘Betrayal of public trust’: Pfizer under fire for resisting Paxlovid [...]
Fast-growing Catalent plots $350M expansion and 1,000 new hires in US
Fast-growing Catalent plots $350M expansion and 1,000 new hires in [...]
COVID-19 vaccine sales slumping now, but analysts optimistic about rebound later this year
COVID-19 vaccine sales slumping now, but analysts optimistic about rebound [...]
J&J, Endo and McKesson settle Alabama opioid litigation for $276M
J&J, Endo and McKesson settle Alabama opioid litigation for $276M [...]
Sanofi tees off work on €400M ‘factory of the future’ in Singapore
Sanofi tees off work on €400M ‘factory of the future’ [...]
Novavax, fashionably late to the COVID-19 vaccine party, could still reap $5B in 2022: analyst
Novavax, fashionably late to the COVID-19 vaccine party, could still [...]
Gilead targets 400 jobs, assembles cell therapy manufacturing troika with FDA nod for Maryland site
Gilead targets 400 jobs, assembles cell therapy manufacturing troika with [...]
Johnson & Johnson, after weak quarter of vaccine sales, will no longer include it in guidance
Johnson & Johnson, after weak quarter of vaccine sales, will [...]
Gilead, after setbacks, aims to pull a third of its revenue from oncology business by 2030
Gilead, after setbacks, aims to pull a third of its [...]
Johnson & Johnson inks $99M opioid settlement with West Virginia: report
Johnson & Johnson inks $99M opioid settlement with West Virginia: [...]